Current Cancer Drug Targets (ERA Journal)

Current Cancer Drug Targets is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Current Cancer Drug Targets issns are issn1: 1568-0096 issn2: 1873-5576.

The fields covered by Current Cancer Drug Targets as part of the evaluation of Australian university research excellence are:

Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)

Oncology and Carcinogenesis Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:

- ACS Combinatorial Science
- ACS Synthetic Biology
- Annual Review of Biophysics
- Anti-Cancer Agents in Medicinal Chemistry
- Biocatalysis and Biotransformation
- Chemistry and Biodiversity
- Current Medicinal Chemistry
- Current Protein and Peptide Science
- International Journal of Cosmetic Science
- Journal of Cancer Biology and Research
- Journal of Chemical Information and Modeling
- Journal of Molecular Medicine
- Methods in Molecular Medicine
- Peptides
- Tetrahedron Letters: the international journal for the rapid publication of all preliminary communications in organic chemistry

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page